Mydecine Innovations Group Inc.

CNSX:MYCO Stock Report

Market Cap: CA$467.4k

Mydecine Innovations Group Management

Management criteria checks 3/4

Mydecine Innovations Group's CEO is Josh Bartch, appointed in Jul 2018, has a tenure of 6.33 years. directly owns 0.61% of the company’s shares, worth CA$2.84K. The average tenure of the management team and the board of directors is 4 years and 4.4 years respectively.

Key information

Josh Bartch

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure6.3yrs
CEO ownership0.6%
Management average tenure4yrs
Board average tenure4.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Josh Bartch's remuneration changed compared to Mydecine Innovations Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-CA$12m

Jun 30 2024n/an/a

-CA$12m

Mar 31 2024n/an/a

-CA$11m

Dec 31 2023n/an/a

-CA$21m

Sep 30 2023n/an/a

-CA$19m

Jun 30 2023n/an/a

-CA$20m

Mar 31 2023n/an/a

-CA$21m

Dec 31 2022CA$445kCA$383k

-CA$16m

Sep 30 2022n/an/a

-CA$23m

Jun 30 2022n/an/a

-CA$18m

Mar 31 2022n/an/a

-CA$24m

Dec 31 2021CA$2mCA$346k

-CA$24m

Sep 30 2021n/an/a

-CA$19m

Jun 30 2021n/an/a

-CA$37m

Mar 31 2021n/an/a

-CA$32m

Dec 31 2020CA$819kCA$153k

-CA$27m

Sep 30 2020n/an/a

-CA$39m

Jun 30 2020n/an/a

-CA$23m

Mar 31 2020n/an/a

-CA$20m

Dec 31 2019CA$238kCA$238k

-CA$21m

Sep 30 2019n/an/a

-CA$5m

Jun 30 2019n/an/a

-CA$5m

Mar 31 2019n/an/a

-CA$11m

Dec 31 2018CA$425kCA$302k

-CA$13m

Compensation vs Market: Insufficient data to establish whether Josh's total compensation is reasonable compared to companies of similar size in the Canadian market.

Compensation vs Earnings: Josh's compensation has been consistent with company performance over the past year.

CEO

Josh Bartch (36 yo)

6.3yrs

Tenure

CA$444,518

Compensation

Mr. David Joshua Bartch, also known as Josh, serves as Chairman of the Board at Mydecine Innovations Group Inc. Mr. Bartch is Co-Founder of Mydecine Innovations Group Inc. and serves as its President, Chie...

Leadership Team

NamePositionTenureCompensationOwnership
David Bartch
Co-Founder6.3yrsCA$444.52k0.61%
CA$ 2.8k
Robert Roscow
Co-Founder4.5yrsCA$455.31k0.21%
CA$ 963.7
Damon Michaels
Co-Founder & COO4.5yrsCA$455.31k0.15%
CA$ 687.8
John Ross
CFO & Corporate Secretary2.2yrsCA$9.20kno data
Sanford Stein
Chief Compliance Officer & General Counsel4.1yrsCA$317.36kno data
Rakesh Jetly
Chief Medical Officer4yrsCA$271.20kno data
Morgan Kervitsky
Director of Marketingno datano datano data
Michel Rudolphie
President of the European Operations3.7yrsno datano data
William Cook
Interim CEO & Technical Director of Mindleap Health Inc.3.5yrsno datano data

4.0yrs

Average Tenure

Experienced Management: MYCO's management team is considered experienced (4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
David Bartch
Co-Founder6.4yrsCA$444.52k0.61%
CA$ 2.8k
Robert Roscow
Co-Founder3.9yrsCA$455.31k0.21%
CA$ 963.7
Anton Gomez-Escolar
Member of Medical4.4yrsno datano data
Vince Polito
Member of Medical4.4yrsno datano data
Denton Hoyer
Member of Medical4.4yrsno datano data
Ruth Lanius
Member of Medicalno datano datano data
Gary Wynn
Member of Medicalno datano datano data
Paul Frewen
Member of Medicalno datano datano data
Rick Barnett
Member of Medicalno datano datano data
Danielle Wise
Member of Medicalno datano datano data
David Erritzoe
Member of Medical4.3yrsno datano data
Robin Carhart-Harris
Member of Medical4.3yrsno datano data

4.4yrs

Average Tenure

Experienced Board: MYCO's board of directors are considered experienced (4.4 years average tenure).